These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12124830)

  • 41. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
    Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
    Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Her-2/neu oncogene amplification determined by fluorescence in situ hybridization.
    Ross JS; Sheehan CE; Fletcher JA
    Methods Mol Med; 2001; 49():93-104. PubMed ID: 21370136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
    Bodey B; Kaiser HE; Siegel SE
    In Vivo; 2005; 19(5):931-41. PubMed ID: 16097449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted therapies in the treatment of germ cell tumors: the need for new approaches against "orphan" tumors.
    Sánchez-Muñoz A; Jiménez-Rodríguez B; Navarro-Pérez V; Medina-Rodríguez L; Llácer C; Vicioso L; Machuca J; Alba E
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):444-51. PubMed ID: 22230258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumors.
    Miyanohara O; Takeshima H; Kaji M; Hirano H; Sawamura Y; Kochi M; Kuratsu J
    J Neurosurg; 2002 Jul; 97(1):177-83. PubMed ID: 12134909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck.
    Olsen RJ; Lydiatt WM; Koepsell SA; Lydiatt D; Johansson SL; Naumann S; Bridge JA; Neff JR; Hinrichs SH; Tarantolo SR
    Head Neck; 2005 Oct; 27(10):883-92. PubMed ID: 16158422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study.
    Aisner SC; Dahlberg S; Hameed MR; Ettinger DS; Schiller JH; Johnson DH; Aisner J; Loehrer PJ
    J Thorac Oncol; 2010 Jun; 5(6):885-92. PubMed ID: 20421818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review of soluble c-kit (s-kit) as a novel tumor marker and possible molecular target for the treatment of CNS germinoma.
    Takeshima H; Kuratsu J
    Surg Neurol; 2003 Oct; 60(4):321-4; discussion 324-5. PubMed ID: 14505850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.
    Torp SH; Gulati S; Johannessen E; Dalen A
    J Exp Clin Cancer Res; 2007 Sep; 26(3):353-9. PubMed ID: 17987795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of EGFR, HER-2/neu and KIT in germ cell tumours.
    Durán I; García-Velasco A; Ballestín C; García E; Martínez-Tello F; Pond GR; García-Carbonero R; Cortés-Funés H; Paz-Ares L
    Clin Transl Oncol; 2010 Jun; 12(6):443-9. PubMed ID: 20534400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of receptor tyrosine kinases in esophageal carcinosarcoma.
    Sano A; Sakurai S; Kato H; Suzuki S; Yokobori T; Sakai M; Tanaka N; Inose T; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Ojima H; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Kuwano H
    Oncol Rep; 2013 Jun; 29(6):2119-26. PubMed ID: 23546020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The erbB/HER type 1 tyrosine kinase receptor family.
    Walker RA
    J Pathol; 1998 Jul; 185(3):234-5. PubMed ID: 9771475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer.
    Kurokawa Y; Matsuura N; Kawabata R; Nishikawa K; Ebisui C; Yokoyama Y; Shaker MN; Hamakawa T; Takahashi T; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S584-90. PubMed ID: 24743909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AKT, EGFR, C-ErbB-2, and C-kit expression in uterine carcinosarcoma.
    Saglam O; Husain S; Toruner G
    Int J Gynecol Pathol; 2013 Sep; 32(5):493-500. PubMed ID: 23896716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas.
    Fukushima S; Otsuka A; Suzuki T; Yanagisawa T; Mishima K; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Narita Y; Shibui S; Kato M; Shibata T; Matsutani M; Nishikawa R; Ichimura K;
    Acta Neuropathol; 2014; 127(6):911-25. PubMed ID: 24452629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors.
    Hechelhammer L; Störkel S; Odermatt B; Heitz PU; Jochum W
    Virchows Arch; 2003 Jul; 443(1):28-31. PubMed ID: 12783324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-erb B2 (Her2/neu) is neither overexpressed nor amplified in hepatic neoplasms.
    Vlasoff DM; Baschinsky DY; De Young BR; Morrison CD; Nuovo GJ; Frankel WL
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):237-41. PubMed ID: 12373150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erb and c-Kit receptors have distinctive patterns of expression in adult and developing taste papillae and taste buds.
    McLaughlin SK
    J Neurosci; 2000 Aug; 20(15):5679-88. PubMed ID: 10908606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.
    Bokemeyer C; Kuczyk MA; Dunn T; Serth J; Hartmann K; Jonasson J; Pietsch T; Jonas U; Schmoll HJ
    J Cancer Res Clin Oncol; 1996; 122(5):301-6. PubMed ID: 8609154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: an Izmir Oncology Group (IZOG) study.
    Salman T; Yildiz E; Yildiz I; Yavuzer D; Unlu M; Varol U; Akyol M; Yildiz Y; Bayoglu V; Kucukzeybek Y; Alacacioglu A
    J BUON; 2015; 20(4):1054-60. PubMed ID: 26416056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.